Methods and compositions for treating pain

Details for Australian Patent Application No. 2006239313 (hide)

Owner Babul, N. Theraquest Biosciences LLC

Inventors Babul, Najib

Agent Pizzeys

Pub. Number AU-A-2006239313

PCT Pub. Number WO2006/116626

Priority 60/675,442 28.04.05 US

Filing date 28 April 2006

Wipo publication date 2 November 2006

International Classifications

A61K 31/19 (2006.01)

A61K 31/34 (2006.01) - having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide

A61K 31/355 (2006.01)

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/501 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/54 (2006.01) - having six-membered rings with at least one nitrogen and at least one sulfur as the ring hetero atoms, e.g. sulthiame

Event Publications

15 November 2007 PCT application entered the National Phase

  PCT publication WO2006/116626 Priority application(s): WO2006/116626

13 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006239315-Enzymes conjugated to antiobodies via a PEG heterobifuctional linker

2006239308-Methods for treating eye conditions